Jim Simons's position in Intellia Therapeutics is currently worth $817 Thousand. That's 0.00% of their equity portfolio (2315th largest holding). The first Intellia Therapeutics trade was made in Q2 2017. Since then Jim Simons bought shares nine more times and sold shares on nine occasions. The investor's estimated purchase price is $1.53 Million, resulting in a loss of 47%.